Page last updated: 2024-11-05

thalidomide and Diverticulitis

thalidomide has been researched along with Diverticulitis in 1 studies

Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.

Diverticulitis: Inflammation of a DIVERTICULUM or diverticula.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sriskandarajah, P1
Scott, F1
Muthalali, S1
Mercieca, J1

Other Studies

1 other study available for thalidomide and Diverticulitis

ArticleYear
Life-threatening bowel perforation while on thalidomide-based triplet regimen for multiple myeloma: a retrospective case series.
    British journal of haematology, 2016, Volume: 173, Issue:5

    Topics: Aged; Aged, 80 and over; Diverticulitis; Female; Humans; Intestinal Perforation; Male; Middle Aged;

2016